Work

BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.7025

Authors: Aparajita Hoskote Chourasia, Hannah Majeski, Angela Pasis, Paul Erdman, Ashwini Oke, David Hecht, David Lonergan, Frank Mercurio, Kyle Chan, Dung Luong Thai, Leah Fung

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286293523

Cites:

Cited by: 22

Related to: 10